Video

Helping Patients Manage High Medication Co-pays

Author(s):

Lauren Santye, Assistant Editor

Deborah Michaelson, MS, RPh, vice president of Operations at Ardon Health, discusses how pharmacies can help patients overcome the cost of high co-pays to maintain specialty drug adherence.

Deborah Michaelson, MS, RPh, vice president of Operations at Ardon Health, discusses how pharmacies can help patients overcome the cost of high co-pays to maintain specialty drug adherence.

Related Videos
Image Credit: © Birdland - stock.adobe.com
Image Credit: © alenamozhjer - stock.adobe.com
Pharmacy, Advocacy, Opioid Awareness Month | Image Credit: pikselstock - stock.adobe.com
Image Credit: © Andrey Popov - stock.adobe.com
Pharmacists, Education, Advocacy, Opioid Awareness Month | Image Credit: Jacob Lund - stock.adobe.com
Pharmacy technician working in a pharmacy -- Image credit: sofiko14 | stock.adobe.com
Team of pharmacists -- Image credit: Jacob Lund | stock.adobe.com
Pharmacist assists senior woman in buying medicine in pharmacy - Image credit: Drazen | stock.adobe.com
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards
Pharmacists working in a pharmacy -- Image credit: Drazen | stock.adobe.com
Related Content
Oral Semaglutide, GLP-1, Diabetes, MACE | Image Credit: Chinnapong - stock.adobe.com
October 29th 2024

Oral Semaglutide Reduces Risk of MACE for Patients With Type 2 Diabetes

Ashley Gallagher, Associate Editor
Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer
October 28th 2024

Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer

Chronic kidney disease, doctor holding model for treatment urinary system, urology, Estimated glomerular filtration rate eGFR - Image credit: manassanant | stock.adobe.com
October 25th 2024

Zaltenibart Receives FDA Rare Pediatric Disease Designation for C3 Glomerulopathy

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment
September 26th 2024

Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment

Gene therapy -- Image credit: RFBSIP | stock.adobe.com
Published: October 25th 2024 | Updated: October 25th 2024

FDA Grants Orphan Drug Designation to MDL-101 for Congenital Muscular Dystrophy Type 1a

Gillian McGovern, Assistant Editor
Aerobic exercise -- Image credit: Kalim | stock.adobe.com
October 24th 2024

Women Beginning Chemotherapy for Breast Cancer Self-Report Improved Cognitive Function When Participating in Aerobic Exercise

Gillian McGovern, Assistant Editor